Skip to content

Warenkorb

Der Warenkorb ist leer.

Gesamt (exkl. MwSt.) £0,00
Warenkorb überprüfen & bezahlen
Antikörper

ATG9B Antibody: ATTO 488

Produktgrößen
100 ug
£511,00
SPC-646D-A488-100UG
Über dieses Produkt
SKU:
SPC-646D-A488
Zusätzliche Namen:
ATG9B, ATG9B_HUMAN, APG9L2, APG9-like 2, Autophagy-related protein 9B, Protein sONE, NOS3AS, Nitric oxide synthase 3-overlapping antisense gene protein
Anwendung:
Immunocytochemistry, Immunofluorescence, Western Blot
Buffer:
640.91mM DMSO, 136.36 mM Ethanolamine, 126.89 mM chlorides, 9.09mM phosphates, 9.09mM NaHCO3
CE/IVD:
Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.
Klonalität:
Polyclonal
Konjugat:
ATTO 488
Konzentration:
1 mg/ml
Weitere Details:
ATG9B is a transmembrane protein essential for autophagy, a cellular degradation pathway critical for maintaining neuronal health. It plays a central role in the formation of cytoplasm-to-vacuole transport (Cvt) vesicles and the organization of the preautophagosomal structure (PAS), the nucleation site for autophagosome biogenesis. By regulating membrane trafficking to the phagophore assembly site, ATG9B ensures the proper initiation and progression of autophagy. In the context of neuroscience, ATG9B is gaining attention for its potential role in neurodegenerative disease mechanisms. Autophagy dysfunction is a hallmark of disorders such as Alzheimer's, Parkinson's, and Huntington's disease, where impaired clearance of protein aggregates and damaged organelles contributes to neuronal loss. ATG9B's involvement in early autophagosome formation positions it as a critical factor in maintaining neuronal proteostasis and synaptic integrity. Although ATG9B is highly expressed in the placenta and pituitary gland, its functional relevance in the central nervous system is increasingly recognized. Emerging studies suggest that modulating ATG9B activity could enhance autophagic flux and mitigate neurodegenerative pathology. Given its upstream role in autophagy and potential impact on neuronal survival, ATG9B represents a promising target for therapeutic intervention in neurodegenerative diseases. Ongoing research aims to elucidate its regulatory mechanisms and interactions within neural tissue.
Host:
Rabbit
Immunogen:
Synthetic peptide from the N-terminal of Human ATG9B (aa. 110-121)
Aufreinigung:
Affinity Purified
Reaktivitäten:
Human, Rat
Versandbedingungen:
Blue Ice
Spezifität:
Detects ~100 kDa.
Lagerbedingungen:
See Manual
Hersteller:
StressMarq Biosciences
Typ:
Antibody: Polyclonal Antibody